$58M Venture Fund Targeted At Life Science Startups; Eli Lilly and Company One of the Contributors

Indy Star -- A new $58 million venture capital fund has been established by BioCrossroads, organizers said today, meaning a huge pool of money to help start-up companies both statewide and nationally.

MORE ON THIS TOPIC